₹67.53
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml is an antibiotic medicine used to treat bacterial infections in children. It is used to treat infections of the skin, throat, ear, and lungs caused by bacteria.
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml contains Amoxycillin and Clavulanic acid. Amoxycillin kills infection-causing bacteria by inhibiting the formation of the bacterial cell wall. Clavulanic acid inhibits the beta-lactamase enzyme, which prevents bacteria from destroying the efficacy of amoxycillin.
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml may cause side effects such as indigestion, diarrhoea, nausea, and stomach pain. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your paediatrician.
Avoid giving Moxori-CV Paediatric Dry Syrup 5 gm/30 ml to your child if she/he is allergic to antibiotics. Keep your doctor informed about your child’s health condition, including his current medications and medical history, to rule out any side effects/interactions.
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml is used in the treatment of bacterial infections in children. The detailed uses of Moxori-CV Paediatric Dry Syrup 5 gm/30 ml are as follows:
Not applicable
-
Not applicable
-
Not applicable
-
Not applicable
-
Consult your doctor
Please consult your doctor if your child has a liver impairment or if you have any concerns regarding this.
Consult your doctor
Please consult your doctor if your child has kidney impairment or if you have any concerns regarding this.
Safe if prescribed
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml is safe for children if prescribed by the doctor. Your paediatrician will decide the dose of the medicine. Do not give your child more than the recommended dose.
Caution
Avoid giving Moxori-CV Paediatric Dry Syrup 5 gm/30 ml to a child with heart problems without a doctor’s approval. Though generally safe, underlying cardiac conditions may require adjusted dosing or alternative antibiotics.
Not applicable
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml is specifically for children use and is not meant for geriatric patients.

Have a query?
The time required for Moxori-CV Paediatric Dry Syrup 5 gm/30 ml to start to work: Moxori-CV Paediatric Dry Syrup 5 gm/30 ml ideally shows its action within 1 to 2 hours after administration.
The time for which the effects of Moxori-CV Paediatric Dry Syrup 5 gm/30 ml last: The effect of Moxori-CV Paediatric Dry Syrup 5 gm/30 ml lasts for 6 to 8 hours.
Drug-Drug Interactions: Inform the doctor if the child is taking antibiotics (cefaclor, cefadroxil, cefixime, cefpodoxime), typhoid or cholera vaccines.
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor before administering Moxori-CV Paediatric Dry Syrup 5 gm/30 ml if your child has any history of kidney or liver disease.
Login/Sign Up
Login/Sign Up
RXDelcure Life Sciences Ltd
₹62
(₹2.07/ 1ml)
RXMankind Pharma Pvt Ltd
₹64
(₹2.13/ 1ml)
RXMankind Pharma Pvt Ltd
₹64
(₹2.13/ 1ml)
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml is used to treat bacterial infections in children.
Moxori-CV Paediatric Dry Syrup 5 gm/30 ml contains amoxycillin and clavulanic acid. Amoxycillin works by inhibiting the formation of the bacterial cell wall (a protective covering) and causing damage to the bacterial cell wall. This eventually leads to the death of the bacterial cell and thus prevents the growth of bacterial infections. Clavulanic acid inhibits the beta-lactamase enzyme, which prevents bacteria from destroying the efficacy of amoxycillin.
No, Moxori-CV Paediatric Dry Syrup 5 gm/30 ml is not used to treat viral infections. It is an antibiotic used only to treat bacterial infections.
No. As Moxori-CV Paediatric Dry Syrup 5 gm/30 ml is an antibiotic, it is advised to complete your child's entire course of treatment as prescribed. If the treatment is stopped abruptly, drug resistance may develop.
Disclaimer
We provide you with authentic, trustworthy and relevant information